M

Mitesco Inc
OTC:MITI

Watchlist Manager
Mitesco Inc
OTC:MITI
Watchlist
Price: 0.3897 USD 18.09% Market Closed
Updated: May 17, 2024

Mitesco Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mitesco Inc
Cost of Revenue Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
Mitesco Inc
OTC:MITI
Cost of Revenue
-$1.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-36%
DaVita Inc
NYSE:DVA
Cost of Revenue
-$8.3B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Cost of Revenue
-$6.2B
CAGR 3-Years
0%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
CVS Health Corp
NYSE:CVS
Cost of Revenue
-$307.3B
CAGR 3-Years
-23%
CAGR 5-Years
-15%
CAGR 10-Years
-11%
Cigna Corp
NYSE:CI
Cost of Revenue
-$180.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Cost of Revenue
-$8.9B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
-9%

See Also

What is Mitesco Inc's Cost of Revenue?
Cost of Revenue
-1.5m USD

Based on the financial report for Mar 31, 2023, Mitesco Inc's Cost of Revenue amounts to -1.5m USD.

What is Mitesco Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-36%

Over the last year, the Cost of Revenue growth was -42%.